Rapport Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome everybody. My name is [Tya Palmi] and I'm welcoming you to the 44th JP Morgan Healthcare Conference. Our next presentation is Rapport Therapeutics, and I would like to invite the CEO, Abe Ceesay for his presentation. Thank you.
Thank you, Ty and thank you to the JPMorgan team and good morning to everybody. Great opportunity today to share our updates here at Rapport Therapeutics. 2025 was a real foundational year for the company. We are entering 2026 in a very strong way and we look forward to sharing those updates with you.
Today, I will be making some forward-looking statements during the presentation, so just regular disclaimer on that. So we would like to really start with the vision of Rapport Therapeutics. This is a company that was created create to build the leading precision neuroscience company.
We realize that precision is somewhat of a loosely used term in our industry. Also, it can be loosely used in neuroscience, but
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
